Multimodal assessment of neuroprotection applied to the use of MK-801 in the endothelin-1 model of transient focal brain ischemia

Moyanova, S.G. and Kortenska, L.V. and Mitreva, R.G. and Pashova, V.D. and Ngomba, R.T. and Nicoletti, F. (2007) Multimodal assessment of neuroprotection applied to the use of MK-801 in the endothelin-1 model of transient focal brain ischemia. Brain Research, 1153 (1). pp. 58-67. ISSN 0006-8993

Documents
1-s2.0-S0006899307007597-main.pdf

Request a copy
[img] PDF
1-s2.0-S0006899307007597-main.pdf - Whole Document
Restricted to Repository staff only

642kB
Item Type:Article
Item Status:Live Archive

Abstract

Transient focal ischemia produced by local infusion of endothelin-1 (ET1) in the territory of the middle cerebral artery has been proposed as a potentially useful model for the screening of drugs developed for the treatment of thrombo-embolic stroke. However, most of the data rely exclusively on the assessment of the infarct volume, which is only a partial predictor of the neurological outcome of stroke. Here, we have validated the model using a multimodal approach for the assessment of neuroprotection, which includes (i) determination of the infarct volume by 2,3,5-triphenyltetrazolium chloride staining; (ii) an in-depth behavioral analysis of the neurological deficit; and (iii) an EEG analysis of electrophysiological abnormalities in the peri-infarct somatosensory forelimb cortical area, S1FL. The non-competitive NMDA receptor antagonist, MK-801 (3Â mg/kg, injected i.p. 20Â min after ET1 infusion in conscious rats) could reduce the infarct volume, reverse the EEG changes occurring at early times post-ET1, and markedly improve the neurological deficit in ischemic animals. The latter effect, however, was visible at day 3 post-ET1, because the drug itself produced substantial behavioral abnormalities at earlier times. We conclude that a multimodal approach can be applied to the ET1 model of focal ischemia, and that MK-801 can be used as a reference compound to which the activity of safer neuroprotective drugs should be compared.

Keywords:dizocilpine, endothelin 1, triphenyltetrazolium, article, brain ischemia, controlled study, drug effect, electroencephalography, neurologic disease, neuroprotection, nonhuman, priority journal, rat, Analysis of Variance, Animals, Behavior, Animal, Brain Infarction, Disease Models, Animal, Dizocilpine Maleate, Endothelin-1, Functional Laterality, Ischemic Attack, Transient, Male, Neuroprotective Agents, Rats, Rats, Wistar, Severity of Illness Index, Somatosensory Cortex, Tetrazolium Salts, Animalia, Rattus
Subjects:B Subjects allied to Medicine > B210 Pharmacology
B Subjects allied to Medicine > B140 Neuroscience
Divisions:College of Science > School of Pharmacy
Related URLs:
ID Code:22161
Deposited On:18 Feb 2016 13:55

Repository Staff Only: item control page